The “A” safety ratings reflect a culture of excellence and continuous improvement.

An imaging system used during brain surgery improves outcomes and reduces the risk of complications.

A new study shows significant improvement in mortality rates.

The new lungs allow teen to end daily treatments and therapies and breathe with ease.

NYU Langone performs the first transplant of a genetically engineered, nonhuman organ to a human.

Brooklyn Heights teen with end-stage heart failure receives a new heart.

Dr. Freya R. Schnabel discusses new surgical technology available for people who have breast cancer.

Renowned pancreatic surgeon and oncologist Dr. Christopher Wolfgang welcomes the toughest cases.

Dr. Nader Moazami is named a “Top 25 Innovator” in safety and quality by Modern Healthcare.

NYU Langone’s innovative fix for curved spines is drawing young athletes worldwide.

A novel approach to treating early-stage nodules saves precious time—and lives.

A team of 500-plus employees achieved a remarkably successful vaccine rollout across 21 locations.

At NYU Langone, few patients are too complex or too sick to be considered for a new heart.

We are bringing high-quality healthcare services to Riverhead and Bridgehampton on Long Island.

Despite the pandemic, the centers surpassed several national quality care benchmarks.

Hospital earns The Joint Commission’s Gold Seal of Approval® for its comprehensive stroke program.

Center for Complex Aortic Disease team performs complex aortic repair with three separate procedures.

Robotic cardiac tumor removal offers more precision and versatility than other surgical methods.

The new outpatient center in East Meadow offers imaging and a variety of subspecialty services.

In a dramatic turnaround, the hospital now maintains one of lowest mortality rates in the nation.

This is the hospital’s fourth Gold Seal of Approval® for Stroke Rehabilitation Certification.